Knowledge and attitudes to personal genomics testing for complex diseases among Nigerians by Lawrence Fagbemiro & Clement Adebamowo
Fagbemiro and Adebamowo BMC Medical Ethics 2014, 15:34
http://www.biomedcentral.com/1472-6939/15/34RESEARCH ARTICLE Open AccessKnowledge and attitudes to personal genomics
testing for complex diseases among Nigerians
Lawrence Fagbemiro1,2* and Clement Adebamowo2,3,4Abstract
Background: The study examined the knowledge and attitudes to personal genomics testing for complex diseases
among Nigerians and identified how the knowledge and attitudes vary with gender, age, religion, education and
related factors.
Methods: Data were collected using qualitative method in 2 districts of the Federal Capital Territory. In the study,
eight (8) Focused Group Discussions (FGDs) and twenty seven (27) Key Informant Interviews (KIIs) were conducted.
Participants for the research were recruited among healthy Nigerians, individuals with complex diseases, health care
professionals, community leaders and health policy makers.
Result: Analysis of the result showed that most respondents in both FGDs and KIIs had limited knowledge about
genomics test initially. Their understanding of the test however improved after explanation on its concept.
Participants showed positive attitude towards genomics tests. Nevertheless they expressed fear over direct to
consumer personal genomics testing, testing unborn babies and disclosure of results to third parties. Culture and
religion were found to influence the perspectives of respondents on genomics test particularly those aspects that
could either directly contradict their beliefs and practices or lead to actions which contradict them.
Conclusion: In conclusion, most Nigerians interviewed had limited knowledge of genomics test but with
supportive attitude towards its use in predicting future risk of complex diseases after understanding the test
concept. Genomics testing for complex diseases was not a common practice in Nigeria.
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Advances in medical technologies have made genomics
tests that predict risk of diseases increasingly available
for use in clinical settings. With the substantial reduc-
tion in cost and its rapid spread around the world, it is
inevitable that genomics tests for complex diseases will
soon be available everywhere including Africa. As the
number of these tests increases, the uses and interpret-
ation of the information they generate will require
increased understanding of genomics and how its princi-
ples apply to different health problems. Such uses are
raising concerns about the ethical issues that may arise
when these technologies are used to identify genetic* Correspondence: fagbemiro2001@yahoo.co.uk
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distribution, and reproduction in any mediummarkers of disease risk in otherwise healthy people. The
concerns including risk of discrimination by schools, in-
surers, or employers [1] are pertinent given that hun-
dreds of genetic markers associated with a variety of
complex diseases, including cancer, diabetes, cardiovas-
cular disease, and Alzheimer disease have been identified
and some of these are now in clinical use [2].
Increasing availability of genomics tests for non-
communicable diseases (NCD) in Nigeria and other
African countries raises the same types of questions as in
developed world. However, there may be additional ethical
dimensions because of the peculiarities of Africans.
Majority of Africans are poor and have high levels of
illiteracy [3], the level of comprehension of genomics
and genomics risk of diseases is therefore uncertain.
While the concept of heritability is well known, subtle
differences such as those between Mendelian or multi-
gene risk of disease may be more difficult.BioMed Central Ltd. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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and health [4], and this may affect their willingness to
do these tests, believe the results and act on the results.
Africans have specific stories of origin, kinship and
personhood that may be challenged by the result of gen-
omics tests and the impact of such interventions on
sense of identity is unknown at this time.
Africans may not have ready access to interventions
that will change the outcomes if they know their genetic
risk of certain diseases. This raises questions about
the ethical implications of conducting such tests and
whether the researchers/test laboratories have an obliga-
tion to provide the required interventions.
To this end, we conducted a qualitative study in
Nigeria, which is the most populous African countries to
assess their attitude to genomics tests for complex dis-
eases, using Focused Group Discussion (FGD) and Key
Informant Interviews (KII). Though Nigeria is the most
populous country in Africa, similar studies need to be
conducted in more African countries to get the general
view of Africans.Methods
A cross-sectional qualitative study was carried out in 2
districts (1 rural and 1 urban) of Abuja, the Federal Capital
Territory (FCT) in Central Nigeria. We conducted 8 FGDs
and 27 KII using topic guides and prompt statements to
elicit participants’ knowledge about general genomics is-
sues, their attitude to personal genomics testing for com-
plex diseases and its determinants. The KII was to extract
more in-depth responses after the FGDs.
Methodological and data triangulation were used to
gain different perspectives on personal genome testing
and to establish the validity of the research studies by
comparing divergence and similarities between the find-
ings from the different data sources and methods [5].
The study was conducted from January to March 2011
and participants were purposively selected.Table 1 Matrix of Key Informant Interview Participants’
Selection among the General Population in the 2 Districts
Category No of Participants per district Total
Urban Rural
Community leader 1 1 2
Opinion leader (male) 1 1 2
Opinion leader (Female) 1 1 2
Christian religious leader 1 1 2
Muslim religious leader 1 1 2
Traditionalist 1 1 2
Head teacher 1 1 2
Student 1 1 2
Total 8 8 16Research setting
Abuja’s population was estimated at 778,567 in 2006
with growth rate of up to 30% a year [6]. Due to its role
as the capital of Nigeria, individuals from all ethnic
groups, tribes and religions in Nigeria live there.
Muslims make up approximately 50% of the population,
Christians 40%, while the remaining people adhere to in-
digenous beliefs4. Abuja has five districts and several
surrounding towns and villages. We selected Asokoro
(Urban) and Bwari (Rural) districts for this study. We
chose a rural and an urban setting for this study in order
to ensure adequate representation of all participants
from diversity of socio-economic background.Data collection
Focus Group Discussions (FGDs)
We conducted 4 FGDs in the urban and 4 in the rural
districts. The categories of participants in each FGD
were: adult male, adult female, youth male and youth
female (youths were selected from 18 yrs to less than
25 years). We ensured that participants in each focus
group were balanced according to the following criteria –
Level of education, Age, Sex, Tribe and Religion. Letters
were sent to participants detailing the objective of the
study and inviting them to participate in the study. Each
session had 10 participants and was conducted by a mod-
erator and a recorder. Participants’ categorization was
based on age and gender because of paternalism that are
prevalent in some Nigeria cultures which might prevent
women and young persons from freely expressing their
opinions in a mixed group. FGDs were conducted separ-
ately for men and women also because of religious sensi-
tivities in Nigeria. Knowledge of participants was assessed
using open ended questions and they were thereafter edu-
cated on the concept before assessing their feelings about
the test.
We conducted a pilot FGD at Karu district of Abuja to
test the study instruments for comprehensibility and
usability. We used the results of the pilot study to mod-
ify our instruments accordingly.
Key Informant Interviews (KII)
We conducted KII with selected health workers who pro-
vide care for individuals with complex diseases, individuals
with complex diseases, relatives of people with complex
diseases, religious leaders, community leaders and opinion
leaders. Respondents were purposively selected to ensure
adequate representation by individuals who can give ad-
equate and relevant information. Tables 1, 2 and 3 show
the distribution of participants in the KII.
The KII were conducted using semi-structured discus-
sion guide. The guides were scenario-based and were
Table 2 Matrix of Key Informant Interview Participants’
Selection at Health Institutions in Urban Districts
Category No of Participants
Hospital Administrator/MD 1




Patient with a complex disease 1
Relative of patient with a complex disease 1
Total 7
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order to elicit more in-depth responses by using follow-
up questions, prompts and probes. The interviews lasted
an average of 30 minutes, were audio-taped, transcribed
and verified by the interviewer prior to analysis.
Data analysis
The interviews were transcribed. In cases where inter-
views were conducted in local languages, they were
translated to English language and back translated into
the local languages to check consistency and accuracy.
Information received was presented verbatim, preserving
language and concept used. Data was analysed using
open coding and grounded theory to ensure that all the
different issues, perceptions and practices that arose
from the interview transcripts were coded. The first
analysis was done by two researchers; the coding and
sub-coding were done manually to show linkages and
networks between the different themes. An independent
researcher reviewed the coding and themes, to ensure
that they reflected the different issues that arose from
the interviews. Category headings were generated from
the data and all of the data were accounted for under
these. Two independent researchers verified the accur-
acy of the categorization and minor modifications were
made to it after their input.
Ethical approval for this study was obtained from the
National Health Research Ethics Committee (NHREC)
of Nigeria.Table 3 Key Informant Interview Participants’ Selection
among Policy Makers at Federal Ministry of Health, Abuja





3 Director Health Planning and Research,
Director Hospital Services and Deputy





A total of 80 individuals participated in the 8 FGDs. Their
ages ranged from 18 to 68 years with mean of 39.5 and SD
20.2 years. There were 39 women (48.75%) and 41 men
(51.25%); 20 Yorubas (25%), 20 Ibos (25%), 21 Hausas
(26.25%) while 19 participants (23.75%) were from other
minority ethnic groups. There were 38 Muslims (47.5%)
and 42 Christians (52.5%). There were 30 students
(37.5%), 20 civil servants (25%), 15 traders (18.75%), 5
teachers (6.25%), 2 health care professionals (2.5%), 2 cler-
gies (2.5%) and 6 from other professions (7.5%).
A. Knowledge of Genomics Tests
From the FGD, most respondents’ knowledge of
genomics tests was limited to paternity and sickle
cell genotype tests during initial assessment. For
example, a participant said:
“..genomics test is done when a couple has a baby and
there is a concern about why the baby does not look
like the father....”
Their understanding however improved after we
educated them on the concept of genomics test. It
was also noted that none of the participants ever
had personal experience of genomics test.
B. Regulation of Genomics Tests
The majority of participants in the FGD saw
genomics test as a professional issue that should be
done within health facilities. Respondents believed
that those in need of the service can be properly
counselled before and after the test if done at health
facilities. To quote a participant,
“…without a professional involvement, it is not ideal to
run such tests. There may be errors in interpreting the
result.”
Participants believed that genomics test results could
be misinterpreted if not done by professionals. In
addition, they felt that patients should have access to
pre and post testing counselling.
On the contrary, some female youths in the rural and
urban centres were of the opinion that genomics tests
should be made available directly to the consumers
with proper education on how to do them. They said,
that would eliminate time wasted at health facilities
and reduce the cost of doing such tests while
increasing accessibility. One of the girls said,
“....it would be fine to do the test yourself if trained
and know if you have future risk of getting a disease
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health professional. ....... So people would not go to the
hospital and waste precious time just to see a doctor
for the test.”
Another female respondent, a student said the test
should be made available directly to the consumer
for confidentiality sake
“....if the test is done in the hospital or laboratory they
may leak the result to a third party who may
stigmatise you because of your genetic
predisposition......this is not good …”
C. Perceptions about relevance of Genomics Tests in
Nigeria
Most participants in the FGD believed that
genomics tests were relevant in Nigeria, even if
there was no access to intervention that would
change outcome of the diseases whose risks could be
detected with genomics test. Respondents said,
doing the test could inform life style modification
and family decisions by the tested individuals.
A respondent said:
“It is still relevant to carry out genomics tests
even though the necessary intervention may not be
available in Nigeria. It is better to know than to be
ignorant....... Knowledge they say is power. There
are steps that can be taken which may not
necessarily be medicine use. It may include
lifestyle modification.”
D.Willingness to do Genomics Tests
All respondents in the FGD were willing to do
genomics tests if available and affordable. Some
male youth participants in the urban area in a
chorus answer said:
“..if it is not expensive, we are willing to do genomics
test....”
E. Disclosure of Result of Genomics Tests to Third
Parties.
Generally, respondents in FGD frowned at
disclosure of test result to a third party. However
some young participants said if their consents were
sought, the result can be disclosed to partners. In
the same discussion, a few elderly respondents said
they would be willing to disclose such result to their
life insurance companies, one of whom said:
“....these are the people that will take care of me if I
am sick, I think they should know.”Participants expressed fear about disclosure of test
result to employers because of the risk of losing
their jobs.
F. Testing and Disclosure of Result to Children.
All participants agreed that children could be tested to
predict if they would have serious diseases in future
but the result should not be disclosed to them until
age of maturity. It was stated that children might not
be able to comprehend or handle such information.
In addition, unfavourable result could cause
irreparable emotional injury to children as some
of them might see it as the end of life.
One respondent, a student said,
“Yes children should be tested. They should not
know the results as they are not yet capable of
taking care of themselves….only the parents should
know.”
G. Genomics Testing of Unborn Babies
Majority of the respondents in the FGD did not
see any reason why unborn babies should be tested
because undesirable result would lead to dilemma
of what to do next. One participant said:
“.... but when the result comes out what will you
do? Will you abort the pregnancy? The best thing
is to leave the unborn alone as testing will bring
problems on what to do next when the result is
not desirable.”
However some of the participants (4 women) in
Asokoro district (urban) were of the opinion that
unborn babies should be tested so that the parents
could start taking precautions or abort the
pregnancy if necessary.
One of the women said:
“It is good to test the unborn children. The earlier one
knows the risk of diseases they are carrying, the
better.”
H. Effect of Religion and Culture
Most respondents in the FGDs claimed that their
attitudes to genomics testing were influenced by
their religion or culture particularly as regards
testing unborn babies. That was observed among
respondents across different ethnic groups and
religions. One of the women said:
“Not good to test the unborn because if the result is
not favourable, it will result in abortion which is
against my religion.”
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There were 27 participants in the KII. Their ages ranged
from 21 to 67 years with mean of 42.0 and SD 13.6 years.
There were 11 women (40.7%) and 16 men (59.26%), 8
Hausas (29.6%), 7 Ibos (26%), 7 Yorubas (26%) and 5
from other ethnic groups (18.4%). There were 16 Chris-
tians (59.26%) and 11 Muslims (40.74%). Nine (9) partic-
ipants were into health care work (33.3%), 4 into
education related activities (14.8%), 2 into business/com-
mercial activities (7.4%) and 12 were community/reli-
gious leaders (44.4%).
A. Knowledge of Genomics Tests
Similar to the result obtained in FGD, most
participants in KII showed limited knowledge of
genomics testing except the young health care
workers. That category of key informants had better
knowledge of genomics tests than others. It was
further observed that most of the key informants
had no personal experience of genomics test.
B. Regulation of Genomics Tests
Majority of the respondents in the KII said gemonic
tests should be conducted by professionals at
designated centres because the concept was new in
Nigeria.
C. Perceptions about relevance of Genomics Tests in
Nigeria
Like participants in the FGD, all respondents in the
KII said genomics tests would be relevant in Nigeria
even with the lack of access to intervention that
could change outcome of genetic risk at the
moment. Health workers could help individuals with
undesirable results think of what to do in order to
alleviate the identified problem or prevent future
manifestation. Results might also help in the
formulation of future health plans for Nigerians by
policy makers. A respondent said:
“It is relevant to still carry out the test even if
interventions are not immediately available in Nigeria.
It is better to know than not knowing because a pre-
disposed individual could take some personal actions
that may prevent the manifestation of the disease.”
D.Willingness to do Genomics Tests
All KII participants showed willingness to do
genomics tests if and when it becomes widely
available in Nigeria. One interviewee said:
“....I am willing to do genomics tests if available as it
will help one to know if there is any future problem
that can quickly be aborted.”E. Disclosure of Result of Genomics Tests to Third
Parties.
Most respondents in the KII said they would not
want their test results disclosed to anyone except
their health insurance company and their spouses. A
male opinion leader in a contrary view said the test
result could be disclosed to anyone or organisation
that could be affected by the result of the test.
Another respondent in the KII however vehemently
said the test result should not be disclosed to a third
party no matter the condition. He said:
“It is a confidential test....I will not want the result of
the test to be disclosed to any third party under any
condition.”
F. Testing and Disclosure of Result to Children.
The KII interviewees also had no hesitation about
testing children but the result should be kept away
from them until they are matured.
G. Genomics Testing of Unborn Babies
Most interviewees expressed displeasure at the
testing of unborn babies. A medical doctor added
that the process of testing might also lead to
abortions; hence he was not in support of testing
unborn babies. A few respondents said testing
unborn babies early in pregnancy would help the
mother decide if termination of the pregnancy was
necessary. A respondent said:
“…if test is done early enough, the pregnancy can be
terminated if that will prevent future agony.”
H. Effect of Religion and Culture
In the KII, majority of the respondents said their
perceptions of genomics test were affected by
religion in situations where the result of test could
lead to abortion or killing of individuals with
undesirable results. One said:
“....my religion will not allow me to support anything
that takes life, so if genomics test will lead to abortion
or killing, I am not in support.”
Discussion
This study showed that most of the respondents, except
a few young health workers did not have a good know-
ledge of genomics test prior to educating them on the
concept. It was notable that the participants showed
positive attitudes towards genomics tests and potential
benefits despite that most of them lacked personal ex-
perience of the tests. A significant proportion expressed
worry over personal genomics testing, testing of unborn
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Some participants also confused personal genomics test
to detect risk of complex diseases with sickle cell geno-
type or paternity tests.
A study by Pagan et al. on possible causes of low
awareness of genetic test information among African
Americans showed that educational level and place of
residency were relevant contributing factors [7]. In our
study, we did not find any difference between the aware-
ness of participants who resided in urban areas and the
outskirts. Conversely, the level of awareness of young
health workers interviewed was relatively higher than that
of others, probably on account of their modern medical
training and clinical experience on genomics tests.
Regulation of genomics test
In the US, geneticists, general public, consumer advo-
cates, and government bodies have raised alarm about
Direct to Consumer Genomics Tests and the risk that
consumers could be misled by false or misleading claims
leading them to make harmful healthcare decisions on
the basis of test results [8]. In our study, most respon-
dents expressed concerns about misinterpretation of test
results if it was not handled by well trained profes-
sionals. On the contrary, younger female respondents sup-
ported out-of-hospital genomics tests because they
believed these would be more confidential and the time
wasting usually associated with hospitals/laboratories visits
would be eliminated. The view of the young women might
be due to their experience of health care systems which
they interact with more than men on account of pregnan-
cies. Their attitude may also be because of greater famil-
iarity with home based tests such as pregnancy tests and
they have come to appreciate the ease and confidentiality
involved. Similarly, Kolor et al. in 2009 in their study re-
ported that women had a more positive attitude towards
personal genomics tests than men [9].
Relevance of genomics test in Nigeria
In this study, respondents generally believed that con-
ducting genomics tests was relevant even if there was no
access to intervention that would change the outcome.
They emphasised that the test result could help in life
style modification, family decision and formulation of fu-
ture health plans for Nigerians by policy makers. This is
similar to the findings of Walker in 2007 on Hunting-
ton’s Disease where he reported that some respondents
chose testing for Huntington’s Disease despite that there
is no treatment for the condition but as an aid in career
and family decisions” [10].
Willingness to do genomics tests
In this study, respondents expressed willingness to do
genomics tests to predict future risk of a complexdisease if offered the opportunity to do so. Their willing-
ness was independent of age, literacy level or sex. This
contrasts with the result of study on primary care
patient by Masanobu et al. in 2013 where age, level of
education, family history of disease positively correlated
with willingness to undergo genomics testing for salt-
sensitive hypertension, and other studies on willingness
to be tested for genetic risk of cancer and other heredi-
tary disease [11].
Disclosure of result to third parties
This study revealed that many people were sceptical
about disclosure of test results to third parties. Most re-
spondents who agreed to disclose test results would only
do so to their spouses and health insurance companies.
That decision might be because of the role health insur-
ance companies and spouses play during sickness.
Health insurance as a means of providing funding for
health care is a novelty in Nigeria and there was no par-
ticularly discernible attitude to them and their work in
Nigeria at present. That might change in future. None of
the study participants agreed to disclose genomics tests
results to employers because of the risk of losing jobs.
The result was similar to the finding of Amy Harmon in
2008 that some individuals avoided genetic testing out
of fear that it would affect their ability to find a job or
keep an existing one if undesirable results were disclosed
to employers [12]. There was only one discordant voice
in the KII who said the test result could be disclosed to
anybody that might be affected by the outcome of the
result even without his consent. That discordant voice
was in line with the view of the majority of foreign juris-
dictions, which were in favour of limited disclosure of
genetic test results (without the consent of the patient)
in cases where the harm to “at-risk” relatives was grave
and imminent and the information could result in effective
intervention [13] ( Knoppers et al. 1998).
Testing and disclosure of result to children
Similar to the result obtained by Keneth et al. in 2011,
as quoted “parents viewed the benefits of pediatric test-
ing to outweigh its risks (positive decisional balance)
and were interested in pediatric testing,” [14] respon-
dents in the study were of the opinion that children
could undergo genomics tests but the result of such tests
should not be disclosed to the children until maturity.
The reason most commonly cited for non-disclosure of
result to minors was because they were too young to
comprehend and take decisions on the basis of the re-
sult. Many parents thought their children might worry
about a positive result, making them unlikely to enrol
their children, or to choose not to tell the child test re-
sults [15] (Bernhardt et al. 2003). Many ethicists believed
that genetic testing for adult-onset conditions generally
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interested in testing has developed mature decision-
making capacities [16] (Committee on Bioethics.2001).
Testing unborn babies
Most participants were against testing unborn babies be-
cause of the risk of harming the foetus and the dilemma
of what to do next if the result was unfavourable. They
did not want to be put in a position where they would
have to consider abortion of the pregnancy as that would
tempt their religious beliefs/faith. Similarly, research by
Adeola et al. in 2012 on prenatal screening for sickle cell
anaemia showed that many respondents would not allow
preventive abortion of pregnancy if screening was posi-
tive because of their religion [17]. “Termination of preg-
nancy by abortion even when there is future risk to the
foetus is considered a sin particularly among Christians”
[18] (Kagu et al. 2004).
Effect of religion and culture
Our respondents claimed that religion and culture
affected their attitude to genomics testing particularly
those aspects that might either directly contradict their
beliefs and practices or lead to actions that contradicted
their religious beliefs. Similarly, a study conducted by
Thomas in 2007, showed that there was a strong reli-
gious influence on attitudes and approaches towards
genomics test testing [19].
Conclusion
From the study, we concluded that most Nigerians inter-
viewed had limited knowledge of genomics test. How-
ever, they showed supportive attitude towards its use in
predicting future risk of complex diseases after under-
standing the test concept. They frowned at testing of un-
born babies, unregulated availability of test, disclosure of
test results to children and a third party. Culture and re-
ligion affected the views of respondents on genomics
test. Genomics testing for complex diseases was not a
common practice in Nigeria.
Limitations of the study
Our study was limited by the use of only qualitative
methods but the findings lay a foundation for more re-
search using other methods to further probe the re-
sponses obtained. In addition, the study was restricted to
Abuja, Nigeria’s capital. Even though Abuja is a cosmo-
politan city with different Nigerian tribes, yet conducting
the study in different parts of the country may reveal dif-
ferent results. Also, the study was limited by the number
of participants, which might not have been a true repre-
sentation of the beliefs and attitudes within the entire
Nigerian population. However it is hoped that the at-
tempt to recruit participants from different ethnicitiesand religions, gender and age, would allow a fair repre-
sentation of different ethnic and religious beliefs.
The study did not explore the willingness of Nigerians
to have genomics tests for specific diseases like Alzheimer
and Huntington Diseases where positive result may carry
severe consequences. Some respondents might not have
fully understood the concept of genomics test despite the
background information given during the interviews, be-
cause genomics test is not a common practice in Nigeria.
Giving the participants a number of multiple choices
or true/false test questions might be a better method to
assess knowledge on genomics test but we used open
ended questions for that part of the study.
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